search icon
  • Print
  • ShareThis
  • Text Size
  • IDSA Calls for Robust NIH Funding to Counter Infectious Disease Threats at Home and Abroad


    On June 22, National Institutes of Health Director Francis Collins will testify before the Senate Labor, Health and Human Services, Education, and Related Agencies Subcommittee on Appropriations on the administration’s NIH budget request for FY2018. The Infectious Diseases Society of America urges Senators to recognize the need to move swiftly to raise the crippling budget caps imposed by sequestration, reject the devastating budget cuts proposed by the administration, and set a course for robust investment in biomedical research.

    Dr. Collins will be joined at the hearing by National Institute of Allergy and Infectious Diseases Director Anthony Fauci. The administration’s proposed budget includes a 23 percent cut to NIAID, which would severely constrain the development of urgently needed new vaccines, diagnostics and therapeutics to address infectious diseases threats that currently include Zika, influenza, HIV/AIDS, and antimicrobial resistance. IDSA recommends at least $4.961 billion in overall funding in FY2018 to grow, not shrink NIAID’s resources and capacity to develop the tools needed to prevent, treat, control and cure infectious diseases, and to protect public health.

    We urge Senators to recognize that the administration’s proposed elimination of the NIH’s Fogarty International Center would come at a cost to our global health leadership and our domestic health security. The elimination of the Center, which supports global health research, would also limit our ability to respond to pandemics and halt our progress in building capacities to drive breakthroughs on leading infectious disease killers that include HIV, tuberculosis, and malaria. In May, IDSA and the HIV Medicine Association initiated a letter signed by 27 leaders of medical and scientific societies to Health and Human Services Secretary Tom Price in support of the Fogarty Center. IDSA urges Congress to retain the Fogarty Center with funding in FY2018 of at least $72 million.

    IDSA is grateful for longstanding bipartisan support in Congress for federal investments in NIH research that protect our nation from infectious diseases threats, and that has most recently been demonstrated by the 2017 omnibus funding bill. We strongly urge Congress to maintain this momentum and reject harmful funding cuts that would reverse progress and put Americans at risk.

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site